Visit our Location
11860 Vista Del Sol Dr Suite 105,
El Paso, TX 79936
Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed

Tag: reverse T3

ChiroMedBlogreverse T3

Hormones: A Comprehensive Guide for Thyroid Optimization

Learn about thyroid optimization for hormones and their vital role in your health. Optimize your thyroid for improved vitality and balance.

Abstract

I wrote this educational post to share how I evaluate and treat persistent hypothyroid symptoms when traditional, TSH-centered therapy falls short. Drawing on my personal journey of living without a thyroid and more than a decade in integrated clinical practice, I explain why patients can feel hypothyroid with “normal” lab values, how the deiodinase system and reverse T3 shape symptoms, and where free T3 offers a more reliable clinical compass. I also detail why some people do better on combination T4/T3 therapy or desiccated thyroid, how nutrient cofactors like iron and selenium transform outcomes, and why lab timing and dose splitting matter. I show where integrative chiropractic care fits by improving autonomic balance, pain, sleep, and movement capacity—factors that directly influence hormone conversion and tissue response. Throughout, I integrate modern, evidence-based research and reference leading studies in endocrinology, cardiology, neurology, and rehabilitation. You will find a precise, step-by-step framework to help patients move from biochemical uncertainty to functional recovery.

The Journey Without a Thyroid and How It Shapes My Care

I practice medicine and chiropractic with a unique perspective. Many patients were required to complete thyroid removal. In the era before recombinant TSH, I experienced diagnostic withdrawal phases that pushed my TSH above 150 mIU/L. They felt the hard edge of metabolic shutdown—cold intolerance, constipation, bradypsychia (slowed thinking), and the kind of profound fatigue that flattens life.

Those deeply personal experiences transformed how I listen to and care for patients. Over the last 14 years, I have provided longitudinal care for more than 9,000 patients with thyroid-related conditions. I repeatedly see the gap between “lab-normal” and truly feeling normal in daily life. Many arrive with TSH values in range on levothyroxine yet still grapple with persistent symptoms.

In my chiropractic practice, I integrate precise spinal adjustments to optimize nervous system function and autonomic balance, thereby directly supporting endocrine regulation and helping close that gap. Patients often describe the full spectrum of thyroid imbalance: classic hypothyroid effects such as fatigue, weight gain, hair thinning, low mood or depression, brain fog, slowed cognition, dry skin, muscle weakness, constipation, cold intolerance, and exercise intolerance; as well as disruptive hyperthyroid symptoms including unintended weight loss despite increased appetite, heat intolerance, anxiety or irritability, rapid heartbeat or palpitations, diarrhea, tremors, restlessness, insomnia, and excessive sweating.

Many therapeutic journeys have reached the same conclusion: many patients need a more nuanced approach than T4 replacement alone—sometimes adding T3, correcting nutrient gaps, addressing gut-liver dysfunction, or resolving autonomic imbalance. These lived lessons anchor the whole-person framework I share here.
References for clinical updates and case observations:
ChiroMed: https://chiromed.com/
LinkedIn: https://www.linkedin.com/in/dralexjimenez/

Thyroid Physiology And Why A Normal TSH Can Mask Low Tissue Thyroid Action

To fully explain persistent symptoms, I begin with the hypothalamic-pituitary-thyroid (HPT) axis and tissue-level control:

  • The hypothalamus releases TRH, prompting the pituitary to release TSH, which signals the thyroid to make T4 and T3.
  • T3 is the bioactive hormone that binds to nuclear thyroid receptors (TRα, TRβ), upregulates mitochondrial and metabolic genes, and drives energy production.
  • Most circulating T3 is made in peripheral tissues by deiodinases. D1 and D2 convert T4 to T3, while D3 shunts T4 into reverse T3 (rT3)—an inactive isomer that competes with T3 for receptor access.

When inflammation, stress, or nutrient deficiency suppress D1 and favor D3, the result is a “low T3–high rT3” pattern. The pituitary, cushioned by local D2 activity, may “feel” replete and keep TSH within range, while muscles, brain, liver, and heart remain T3-deficient. This is how people feel hypothyroid despite a “normal” TSH.

  • Deiodinase and tissue signaling overview: (Bianco & Kim, 2018)
  • Non-thyroidal illness and low T3 physiology: (Peeters, 2017)
  • Transporter and receptor influences on intracellular signaling: (Friesema et al., 2010)

Citations:

Why Free T3 Predicts Function Better Than TSH During Treatment

In practice and research, free T3 correlates more tightly with energy, thermoregulation, cognition, and cardiometabolic outcomes than TSH when therapy is underway. While TSH is an excellent screening tool in untreated populations, it does not reliably reflect tissue thyroid status once exogenous hormone is introduced. Peripheral tissues depend on D1, which is easily downregulated by stress and illness. The pituitary’s reliance on D2 allows TSH to normalize even as free T3 remains low or rT3 rises.

  • Cardiovascular findings consistently link low T3 with worse outcomes; TSH often shows weak or no association (Dimitriadis et al., 2014; Iervasi et al., 2010).
  • In critical illness and ARDS, low T3 predicts higher mortality and delayed recovery (Wajner & Maia, 2015).

Citations:

The Reverse T3 Brake And The Conversion Ecology

I teach patients to think of reverse T3 as a physiologic brake. Under stress, inflammation, infection, caloric restriction, or high T4 loads, D3 increases and shunts T4 into rT3. Elevated rT3 effectively blocks T3’s action by competing for receptor and transport access.

  • Symptoms of high rT3/low T3: fatigue, cold intolerance, constipation, dry skin, sluggish thinking, reduced exercise tolerance.
  • Clinical reasoning: Adding more T4 in a high rT3 state often worsens the problem by feeding the brake. We must address stressors, reduce inflammation, optimize cofactors, and, when indicated, add physiologic T3.

Mechanistic reviews:

Levothyroxine Alone: When The Assumptions Fail

The traditional assumption was that T4-only therapy would convert adequately to T3 and fully resolve symptoms. Many patients do improve on levothyroxine. Yet a meaningful proportion remain symptomatic because of impaired conversion or high rT3.

  • Genetic polymorphisms (e.g., DIO2 Thr92Ala) and inflammatory states alter T3 production and action (Panicker et al., 2009).
  • Caloric restriction, illness, and iron deficiency shift deiodinase activity away from T3 (Stott et al., 2019).

A physiologic alternative is to use combination therapy (T4 + T3) or desiccated thyroid (DTE) for select patients with persistent symptoms, carefully titrated and monitored for safety.
Citations:

The Testosterone Connection And Metabolic Synergy

Thyroid hormones and androgens co-regulate metabolic rate, muscle protein synthesis, and mitochondrial efficiency:
Hypothyroidism can downregulate androgen receptors; low testosterone reduces muscle mass and worsens fatigue (Kelly & Jones, 2015).

  • Thyroid hormones increase SHBG, thereby altering the free fractions of testosterone and estradiol (Davis & Wahlin-Jacobsen, 2015).
  • Visceral adiposity increases aromatase activity, further lowering free testosterone. Optimizing thyroid action reduces central fat and indirectly improves androgen balance.

Citations:

An Evidence-Guided Evaluation Framework I Use In Clinic

To identify root causes of persistent symptoms, I apply a structured model:

  • Comprehensive thyroid panel and dynamics
    • TSH, free T4, free T3, and reverse T3 to map supply, conversion, and braking.
    • Thyroid antibodies (TPOAb, TgAb) for autoimmunity surveillance.
    • Consistent lab timing relative to dosing.
  • Nutrient and hematologic status
    • Ferritin, iron indices, selenium, zinc, vitamin D, vitamin A, B12; iodine assessment when indicated and carefully monitored.
    • Rationale: cofactors enable hormone synthesis and conversion (Zimmermann & Köhrle, 2002).
  • Inflammation and metabolic health
    • hsCRP, fasting insulin, HOMA-IR, lipids, liver enzymes; body composition for lean mass and visceral fat.
  • Gut-liver axis
    • Screen dysbiosis/SIBO symptoms, celiac markers, NAFLD risk, bile flow, and constipation patterns (Docimo et al., 2021).
  • Autonomic nervous system and stress load
    • HRV, orthostatic vitals, sleep quality, perceived stress.
  • Sex hormones and adrenal rhythm (as indicated)
    • Total and free testosterone, SHBG, estradiol, LH/FSH; DHEA-S; consider cortisol profiles when warranted.

Citations:

Precision Dosing: Why Lab Timing And Dose Splits Matter

When I incorporate T3 (liothyronine) or use desiccated thyroid, I standardize lab draws at five to six hours after the morning dose and split doses to avoid peaks:

  • Pharmacokinetics: Oral T3 peaks about 1–2 hours after ingestion and declines over the next several hours. Drawing at 5–6 hours captures a mid-curve snapshot that is comparable across visits (Ross, 2022; Jonklaas et al., 2019).
  • Dose splitting: I typically use BID or TID schedules (e.g., 6:00 a.m., 12:00 p.m., 6:00 p.m.) to maintain steady intracellular T3 for mitochondrial throughput, cognitive function, and thermoregulation. This dramatically reduces palpitations and anxiety tied to early peaks.
  • Wearables: I ask patients to track heart rate and sleep. Post-dose pulse spikes confirm kinetic peaks and guide redistribution.

Citations:

Combination Therapy And Desiccated Thyroid: How I Use Them And Why

I consider combination T4/T3 or desiccated thyroid extract (DTE) for patients with persistent symptoms and a lab pattern of low free T3 and/or elevated rT3:

  • Start low and titrate slowly
    • Introduce small, divided T3 doses to avoid peak-related side effects.
    • Maintain a baseline T4 level for substrate, while ensuring receptor activation by T3.
  • DTE practicals
    • Typical starting range: 1–1.5 grains (60–90 mg) daily, individualized to prior T4 dose and sensitivity.
    • Transition approach: a two-week half-and-half overlap (half prior T4 dose plus half new DTE dose) to avoid T3-naïve jitters.
    • Limit large single doses; distribute across the day if a higher total daily dose is needed.
  • Monitoring
    • Symptoms, free T3, free T4, and safety markers (heart rate, blood pressure).
    • Long-term: bone density surveillance when higher T3 exposures are used in specific populations.

Evidence-based and patient preference data:

Nutrient Therapy That Changes Outcomes: The Thyroid

The thyroid hormone is a signal, but the body needs substrates and cofactors to translate that signal into action. I routinely assess and treat:

  • Iron repletion when ferritin is low (often targeting >50–70 ng/mL for thyroid optimization)
    • Iron supports thyroid peroxidase and deiodinase function; low ferritin levels blunt T4-to-T3 conversion and can mimic hypothyroid symptoms.
  • Selenium (100–200 mcg/day from diet/supplement)
    • Supports deiodinase activity and antioxidant defense; may modestly reduce TPO antibodies (Winther et al., 2020).
  • Zinc, vitamin D, vitamin A, and B12
    • Zinc facilitates receptor function; vitamin D modulates immune tone and muscle; vitamin A supports epithelial and receptor dynamics.
  • Protein sufficiency (often 1.2–1.6 g/kg/day)
    • Supports thyroid transport proteins, hepatic conversion, and muscle mass.

Citations:

Integrative Chiropractic Care: Autonomic Regulation, Pain Reduction, And Metabolic Performance

As a DC and APRN, I see daily how neuromusculoskeletal health and the autonomic nervous system shape endocrine outcomes. Integrative chiropractic care fits into thyroid optimization by:

  • Autonomic regulation
    • Gentle spinal manipulation and soft-tissue techniques reduce nociceptive input and sympathetic overdrive, improving vagal tone and HRV. Lower stress signaling supports D1 activity, reduces rT3, and improves sleep quality.
  • Pain reduction
    • By reducing chronic pain, we lower inflammatory cytokines (e.g., IL-6, TNF-α) that suppress deiodinases and disrupt sleep, thereby enabling better hormone conversion and tissue responses.
  • Movement-based care
    • Structured resistance training and aerobic intervals, guided by movement assessment, improve insulin sensitivity, GLUT-4 translocation, and mitochondrial density, amplifying T3’s metabolic impact.
  • Breath and posture
    • Thoracic mobility and diaphragmatic breathing enhance oxygenation, vagal tone, and sleep—key supports for endocrine stability.


Clinical observations:
In my practice at ChiroMed, patients who pair optimized thyroid therapy with chiropractic autonomic optimization, mobility work, and progressive strength programming recover faster, maintain better energy, and sustain fat loss more reliably. See clinical reflections and case pearls:

Metabolic Rehabilitation: Building A Physiology That Welcomes T3

Thyroid optimization alone rarely solves modern metabolic challenges. I employ a pragmatic blueprint:

  • Build muscle first
    • Two or more weekly full-body resistance training sessions with progressive overload. More muscle equals a higher basal metabolic rate and better glucose disposal.
  • Walk the thermostat
    • 7,000–10,000+ daily steps, with postprandial 10–15-minute brisk walks, to blunt glucose excursions and lower inflammation.
  • Prioritize sleep and rhythm.m
    • Stable sleep-wake times, morning light exposure, and evening light reduction improve HPT-axis signaling and insulin sensitivity.
  • Protein-forward nutrition
    • 25–40 g protein per meal; fiber-rich plants and healthy fats; minimize ultra-processed foods.
  • Micronutrient sufficiency
    • Emphasize seafood (selenium, iodine), lean meats (iron, zinc, B12), eggs (vitamin A), and leafy greens (folate, magnesium).
  • Stress modulation
    • Breathing practices, HRV-guided recovery, and time in nature lower cortisol and rT3.
  • Manual and chiropractic care
    • Identify and correct joint restrictions and postural dysfunctions that limit training and raise sympathetic tone.

Epidemiologic context: U.S. obesity prevalence continues to rise, underscoring the need to embed thyroid care within a broader metabolic strategy (CDC, 2023).
Citation:

Thyroid Dysfunction-Video

Safety And Monitoring: Cardiac And Bone Health With T3

I titrate T3 conservatively and monitor:

  • Cardiac status (resting pulse, symptoms; ECG as indicated in arrhythmia-prone patients).
  • Bone health (ensure adequate calcium and vitamin D, prioritize resistance training, and follow DEXA for at-risk individuals).
  • Symptoms and function (energy, thermoregulation, bowel rhythm, cognition, sleep).
  • Free T3/Free T4, with TSH interpreted cautiously under T3-containing regimens.

A key clinical distinction: TSH suppression on therapy is not the same as endogenous hyperthyroidism. In thyroid cancer cohorts, carefully managed TSH suppression does not universally increase atrial fibrillation or osteoporosis risk when free hormones and clinical markers are appropriately monitored. We individualize targets rather than relying on a single lab threshold.
Reviews:

Standardizing Testing: Reducing Noise And Improving Decisions

The most powerful lever in precision thyroid care is standardization:

  • Fix dosing times (e.g., 6:00 a.m., 12:00 p.m., 6:00 p.m.).
  • Lock blood draws at five to six hours after the morning dose.
  • If patients arrive outside the window, reschedule to keep results comparable.
  • Use simple EMR notes to track outcomes: “Free T3 improved; patient reports better focus and energy; no adverse effects at standard draw; pulse stable.”

This rigor transforms guesswork into reliable, reproducible decisions.
Citations:

Case Patterns From Practice: How The Physiology Plays Out

The “stuck but strict” patient

  • A woman on levothyroxine with normal TSH but persistent fatigue and weight gain. Ferritin was 18 ng/mL; vitamin D was 22 ng/mL; rT3 was elevated. After iron and vitamin D repletion, post-meal walking, and low-dose T3 add-on, energy rose within weeks. Resistance training resulted in a 6% relative reduction in body fat over four months; we later tapered levothyroxine as conversion normalized.

The “pain-metabolism loop.”

  • A man with low back pain avoided exercise and gained weight while on stable thyroid replacement therapy. Integrative chiropractic care reduced pain and improved mobility. We added a graded strength plan and sleep coaching; HRV improved. With modest T3 addition, he reported clearer thinking and greater stamina.

The”testosterone trap.”

  • A man sought testosterone for fatigue and low libido. Evaluation revealed low-normal free T3, elevated rT3, high stress, and poor sleep. We prioritized thyroid optimization, sleep, and resistance training. Free testosterone improved without exogenous testosterone; symptoms resolved.

Clinical notes and similar cases:

Practical Steps For Patients And Clinicians

Patients

  • Ask for a comprehensive thyroid panel: TSH, free T4, free T3; consider reverse T3 if symptoms persist.
  • Check ferritin, selenium, zinc, vitamin D, and B12; discuss iodine only with clinical guidance.
  • Standardize dosing times and lab draw timing; split doses if needed to reduce peaks.
  • Build muscle, walk after meals, and protect sleep; track pulse and sleep with wearables if possible.
  • Consider integrative chiropractic care to improve pain, autonomic balance, and movement capacity.

Clinicians

  • Treat the person, not just the lab. If symptoms persist with “normal” TSH, investigate conversion ecology, cofactors, and comorbidities.
  • Consider cautious T4/T3 combination or DTE trials with standardized monitoring and safety tracking.
  • Pair endocrine therapy with nutrition, sleep, stress care, and chiropractic/rehab partners.
  • Reassess as inflammation, body composition, and fitness improve; the right dose today may be excessive in six months.

Closing Perspective: Aligning Therapy With Physiology

Living without a thyroid taught me respect for the complexity of endocrine physiology and the limits of single-number thinking. Care improves when we align therapy with how the body actually works: ensure adequate hormone supply; correct cofactor deficiencies; calm the autonomic nervous system; build muscle; and remove friction points such as pain, inflammation, and poor sleep. When we combine personalized thyroid replacement, targeted nutrient therapy, and integrative chiropractic care within a metabolic rehabilitation framework, patients stop treading water and begin moving forward.

References

SEO tags: thyroid optimization, free T3, reverse T3, deiodinase enzymes, levothyroxine, liothyronine, T4 T3 combination therapy, desiccated thyroid, ferritin and thyroid, selenium thyroid, autonomic balance, integrative chiropractic care, HRV thyroid, lab timing thyroid, split dosing T3, Hashimoto’s treatment, metabolic rehabilitation, resistance training hypothyroidism, gut liver thyroid axis, suppressed TSH safety, Dr. Alexander Jimenez,

Hormone Balance, Iron Health, and Contraceptive Care

Hormone Balance, Iron Health, and Contraceptive Care

Hormone Balance, Iron Health, and Contraceptive Care

Abstract

As a clinician blending chiropractic, functional medicine, and advanced nursing practice, I see how hormone physiology, micronutrients, and systems biology converge to shape health, recovery, and resilience. In this educational post, I walk you through practical, evidence-informed strategies for evaluating iron deficiency and ferritin; interpreting cortisol and thyroid dynamics; selecting and titrating progesterone, estrogen, and testosterone in complex scenarios (PCOS, IUD selection, male fertility and TRT rebound, TIA and stroke risk considerations, endometriosis, and menopause); and understanding the nuanced oncology context around DCIS and hormone receptors. I also explain how integrative chiropractic care fits into these plans by balancing the nervous and hormone systems, improving body functions, and supporting health through hands-on therapy, exercise, sleep, and diet. Throughout, I present current literature from leading researchers and add real-world observations from my practice (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST) to help you translate physiology into precise, patient-centered care.

Foundations Of Identity In Care Planning And Clinical Context

  • Why this matters: Many patients navigate multiple identities—athlete and parent, caregiver and executive, patient and advocate. Clinically, multiple identities often map onto competing physiological stresses: sleep compression, high allostatic load, and variable patterns of nutrition and movement. Recognizing these factors is the first step in aligning care with lived realities.
  • Integrative chiropractic fit: In my clinic, identity-informed care plans build adherence. When I address spine and fascial mechanics and autonomic balance with targeted manual therapy, patients experience immediate relief that reinforces engagement with longer-term hormonal and nutritional strategies. Clinically, I see better follow-through on lab timing, supplement dosing, and structured movement when the body feels aligned and capable.

Iron Physiology, Ferritin, And Root-Cause Mapping

Understanding iron requires separating storage, transport, and utilization:

  • Key biomarkers:
    • Serum ferritin: a proxy for iron stores but an acute-phase reactant—elevates with inflammation (hepcidin-mediated sequestration).
    • Serum iron and transferrin/TIBC: reflect circulating iron and binding capacity.
    • Transferrin saturation (%): often the most useful single index with ferritin.
    • Reticulocyte hemoglobin (CHr) and soluble transferrin receptor (sTfR): help distinguish true deficiency from anemia of inflammation.

Physiology in brief:

  • The liver peptide hepcidin governs iron absorption and release from macrophages. Inflammation increases hepcidin, lowering absorption and locking iron in stores—low iron availability with normal/high ferritin.
  • True iron deficiency presents with low ferritin, low iron, high TIBC, and low transferrin saturation. Anemia of chronic inflammation shows low iron, low/normal TIBC, and normal/high ferritin.

Why patients stay iron-deficient:

  • Decreased intake or high phytate/polyphenol diets limit absorption.
  • Malabsorption: hypochlorhydria, celiac spectrum, SIBO, gastric bypass.
  • Losses: heavy menses, GI blood loss, frequent phlebotomy, and endurance training.
  • Special populations: neonates can experience early postnatal physiologic shifts; in adults, postpartum, post-surgery, and endurance athletes require tailored screening.

Clinical approach I use:

  • Map the cause: hydration status, GI absorption, occult bleeding (including fecal immunochemical testing), menstrual history, PPI use, celiac panel if indicated, and inflammatory markers (CRP, ESR).
  • Replace iron physiologically: I favor alternate-day oral iron to align with hepcidin’s diurnal rhythm and reduce GI side effects, supported by recent randomized trials showing improved absorption with every-other-day dosing (Stoffel et al., 2017). Using ferrous bisglycinate or heme iron polypeptide can enhance tolerance.
  • Repletion targets: Bring ferritin to symptom-relief thresholds (often 50–100 ng/mL for fatigue and hair loss), then sustain. Monitor hemoglobin, ferritin, and transferrin saturation every 8–12 weeks during repletion.

Integrative chiropractic fit:

  • Manual therapies that improve thoracic mobility and diaphragmatic excursion enhance vagal tone and GI perfusion, supporting absorption. Coaching on timing iron away from calcium and with vitamin C-rich foods further increases uptake. I often see faster symptom improvement when we combine postural breathing retraining and gentle aerobic conditioning with iron repletion.

Hormonal IUDs, Progestin Families, And Thrombotic Risk

Not all progestins are the same. Families differ in androgenicity and thrombotic risk:

  • Levonorgestrel (Mirena and similar): primarily a local uterine effect with low systemic levels; robust evidence supports low VTE risk compared with systemic progestins (ACOG, 2022).
  • Norethindrone: different side-effect profile and hepatic metabolism from progesterone; systemic exposure carries VTE risk similar to combined oral contraceptives when used in combination with estrogen.
  • Biologic progesterone (micronized) differs from synthetic progestins in receptor activity and in metabolites (e.g., allopregnanolone), which influence mood and sedation.

Why are Levonorgestrel IUDs often well tolerated?

  • The local endometrial action results in reduced systemic exposure, decreased bleeding, and endometrial protection, with a favorable safety profile. This is one reason neurosurgical and periprocedural contexts prefer local or targeted effects when feasible—namely, to reduce systemic adverse events.

Integrative chiropractic fit:

  • Pelvic floor integration matters. I routinely coordinate pelvic floor assessment and diaphragmatic mechanics with IUD choice. Improved lumbopelvic control and reduced sympathetic arousal can decrease cramping and improve IUD tolerance.

Progesterone Strategy In Sensitive Patients And PCOS Contexts

Clinical problem: Some patients with PCOS or HPA dysregulation report mood lability with oral progesterone.

Physiology:

  • Oral micronized progesterone converts to allopregnanolone, a positive allosteric modulator of GABA-A receptors. In most, this is anxiolytic; in a sensitive minority, neurosteroid fluctuations can provoke dysphoria.
  • Sublingual and transdermal routes bypass some first-pass metabolism, altering metabolite profiles and CNS effects.

My approach:

  • Start with a low-dose oral micronized progesterone (e.g., 100 mg qHS) to promote sleep and provide endometrial protection. If not tolerated:
    • Switch to a sublingual troche at half the equivalent oral dose (sublingual tends to achieve higher bioavailability; clinically, 100 mg sublingual can approximate 200 mg oral).
    • Quartering a 200 mg troche yields ~50 mg sublingual aliquots for fine titration.
  • Why this works: By modulating route and dose, we can smooth neurosteroid peaks, reduce daytime sedation, and maintain endometrial safety when used with estrogen.
  • For PCOS on androgen therapy: Balance is critical. A small androgen signal can be synergistic for mood, energy, and libido, but carefully calibrate it with estrogen and progesterone to avoid endometrial hyperplasia, acne, or dyslipidemia. Track SHBG, lipids, and insulin resistance.

Integrative chiropractic fit:

  • Autonomic stabilization through cervical-thoracic manipulation and breathing retraining reduces adrenergic drive that often amplifies progesterone sensitivity. When we address sleep quality and nocturnal bruxism with TMJ and cervical work, I see smoother adaptation to progesterone in practice.

Cortisol Testing: Salivary Profiles Versus Serum

Why measure multiple points:

  • Cortisol follows a diurnal curve: a peak within 30–45 minutes after waking (CAR) and a gradual decline throughout the day. A single AM serum cortisol measurement may miss dysregulated patterns.
  • A 4–5-point salivary cortisol series captures CAR, midday, afternoon, and evening levels—useful for sleep disturbances, burnout, and suspected HPA axis alterations (O’Connor et al., 2021).

When I choose each:

  • For pattern analysis and sleep complaints: multi-point salivary cortisol.
  • For adrenal insufficiency screening or acute illness: AM serum cortisol ± ACTH stimulation.

Integrative chiropractic fit:

  • Chiropractic care and breath-led movement can normalize autonomic balance, often flattening hyper-adrenergic spikes that correlate with evening cortisol elevations. I pair care with light-in-the-morning, dim-in-the-evening routines to reinforce circadian rhythms.

Male Fertility, Clomiphene, And TRT Rebound

In men in their 20s–30s with low testosterone who want fertility:

  • I avoid long-term estrogen receptor blockade. Short courses of clomiphene citrate (3–6 months) can increase LH/FSH levels, thereby increasing endogenous testosterone and sperm counts (Helo et al., 2017). It is not for indefinite use due to visual and mood risks and potential lipid changes.
  • Off peptides/TRT: I use timed clomiphene or enclomiphene to accelerate spermatogenesis while lifestyle and nutrition restore HPG axis tone.
  • Foundational first: For younger men, I prioritize diet quality, sleep, resistance training, weight normalization, and correcting micronutrient levels (vitamin D, B-complex, zinc, magnesium). I frequently see total testosterone rise from low 300s into 700–800 ng/dL over 6–9 months with lifestyle adherence.

Integrative chiropractic fit:

  • Restoring thoracic mobility and rib mechanics improves breathing efficiency and training capacity; correcting lumbopelvic mechanics reduces systemic inflammation from overuse. The autonomic shift toward parasympathetic tone deepens sleep, which is crucial for nocturnal gonadal hormone secretion.

DCIS, Hormone Receptors, And Personalized Risk-Benefit

Terminology and nuance:

  • Ductal carcinoma in situ (DCIS) is a noninvasive neoplastic process confined to the ducts. While often called “stage 0 breast cancer,” it lacks stromal invasion; management varies widely.
  • Receptor positivity (ER, PR, AR) indicates ligand-responsive pathways. Receptors are normal cellular features; their presence does not inherently mandate systemic suppression in all contexts.

Standard-of-care realities:

  • Many oncology pathways default to anti-estrogen strategies (e.g., tamoxifen) in receptor-positive lesions. My stance: align with oncology for invasive disease or recent treatment, but individualize for remote history or post-mastectomy scenarios, considering symptom burden and quality-of-life outcomes (Early Breast Cancer Trialists’ Collaborative Group, 2011; Cuzick et al., 2011).

Clinical reasoning:

  • In a patient decades post-bilateral mastectomy with no residual breast tissue, the theoretical tissue-specific risk is different from that of a patient 6 months post-lumpectomy still on adjuvant therapy. I weigh the systemic benefits of estrogen (bone, vasomotor stability, cognition, urogenital health) against realistic tissue risks, use shared decision-making, and document this via informed consent.

Integrative chiropractic fit:

  • Many of these patients struggle with pain, sleep disruption, and deconditioning. Postural restoration, scar mobility work, and gentle strengthening reduce sympathetic load, allowing lower-dose hormone regimens to achieve symptom control.

TIA, Stroke Risk, And Sex Hormones

Historical concern has linked estrogen to stroke risk, particularly in oral forms and in older trials with higher doses started late after menopause. The modern view:

  • Route matters: Transdermal estradiol has a more favorable thrombotic profile than oral estradiol because it bypasses first-pass hepatic effects on clotting factors (Canonico et al., 2016).
  • Testosterone does not require routine discontinuation after TIA in carefully selected women and men; the focus is on global vascular risk management (blood pressure, glycemic load, sleep apnea, hematocrit monitoring in men on TRT).
  • In patients who received pellet therapy near a TIA event, I evaluate vascular risks comprehensively. Anecdotally and mechanistically, sustained androgen levels do not necessarily precipitate cerebrovascular events; confounding factors (dehydration, arrhythmia, migraine with aura, hypercoagulable states) must be assessed.

Why integrative care helps:

  • Cervical and upper thoracic biomechanical dysfunction can aggravate headaches and sympathetic tone. By improving cervical proprioception, rib mechanics, and breathing patterns, I observe reduced migraine frequency and better control of blood pressure variability, which complements hormone prudence.

Immediate-Release Versus Extended-Release In Symptom Relief

In my practice, I often choose immediate-release formulations when seeking neurosensory benefits (e.g., anxiolysis, sleep initiation) from agents with CNS effects because:

  • Faster onset can more directly target symptom windows (e.g., bedtime).
  • It allows finer titration and identification of dose-response relationships.

When I choose extended-release:

  • For hormones or agents where steady state is crucial to avoid peaks/valleys, or when side effects are dose-peak-related. Personalization is key.

Endometriosis And Menopause: Progesterone Essentials

Key principles:

  • In menopausal women with a history of endometriosis on estrogen therapy, I favor co-prescribing progesterone even without a uterus. Rationale: ectopic endometrial implants may persist extrauterine and remain hormonally responsive. Progesterone has anti-proliferative effects on endometrial tissue and may reduce the risk of malignant transformation (Vercellini et al., 2014).

Testosterone and endometriosis:

  • Testosterone generally has neutral direct effects on endometriotic lesions; symptom modulation is more indirect (energy, libido, mood). I monitor acne, hair growth, and lipids.

Integrative chiropractic fit:

  • Pelvic and lumbosacral mechanics impact pelvic congestion and pain. Coordinated pelvic floor therapy, sacroiliac mobilization, and graded movement often reduce pain and allow lower estrogen doses with better function.

Thyroid Physiology: T4, Reverse T3, And Desiccated Thyroid

Why do some patients struggle with isolated levothyroxine?

  • T4 to T3 conversion is context-dependent: inflammation (IL-6), chronic stress (cortisol), and caloric restriction increase deiodinase 3, generating reverse T3 as a protective brake.
  • Bolus T4 dosing can, in sensitive patients, drive higher reverse T3 and leave tissues relatively hypothyroid despite normal TSH and free T4.

When I consider combination therapy:

  • If free T3 is low-normal with symptoms and reverse T3 is elevated, a trial of T3 addition or desiccated thyroid can be considered, monitoring HR, BP, and symptoms.
  • Desiccated thyroid includes T1/T2 in addition to T4/T3; while evidence is mixed, some patients report improved well-being (Hoang et al., 2013). The physiologic appeal is a more native ratio of iodothyronines.

Dosing logic:

  • Keep total T3 exposure rational (avoid overtreatment). Many patients do well at conservative desiccated doses (e.g., 60–120 mg with split dosing) or modest liothyronine add-on.
  • If reverse T3 is persistently high, look upstream: inflammation, gut dysbiosis, iron deficiency, sleep apnea, and medications. Raising the dose alone rarely fixes a conversion problem.

Integrative chiropractic fit:

  • By improving sleep quality and decreasing pain, we reduce cortisol and catecholamine tone that can impair peripheral conversion. I frequently pair thyroid adjustments with gut-directed nutrition, iron repletion, and aerobic conditioning to normalize deiodinase activity.

Estriol, Estradiol, And Skin Or Urogenital Targets

  • Estriol (E3) is a weaker estrogen with higher affinity for ER-beta, associated with urothelial and skin benefits and a theoretical reduced proliferative risk profile (Labrie et al., 2017).
  • On its own, estriol is often too weak for vasomotor symptoms; patients may continue to have hot flashes with estriol pellets or low-dose creams.
  • Bi-est combinations (estriol + estradiol) can increase serum estradiol; monitor for bleeding. For vulvovaginal atrophy, low-dose local estradiol or estriol is typically effective with minimal systemic absorption.

Integrative chiropractic fit:

  • Postural improvement, hip mobility, and pelvic floor coordination augment local tissue perfusion and sexual function. Patients often need lower topical doses when musculoskeletal contributors are addressed.

TRT In Men: Hematocrit, Estradiol, And Practical Monitoring

For men on testosterone injections who feel great but develop high hematocrit:

  • Tactics include dose and interval adjustments, switching to transdermal forms, therapeutic phlebotomy if indicated, and addressing sleep apnea, hydration, and iron stores.
  • I monitor hematocrit, estradiol, SHBG, PSA, lipids, and blood pressure. Aromatization to estradiol can be beneficial for bone and mood; I avoid reflexive overuse of aromatase inhibitors and instead optimize dose and lifestyle.

Integrative chiropractic fit:

  • Correcting thoracic outlet and rib mechanics can support breathing and reduce sleep apnea severity alongside weight loss—a key driver of safer TRT hematology.

Gut-First When Thyroid Therapy “Should Work” But Doesn’t

When free T3 is approaching the target (e.g., 4.0+ pg/mL), yet patients still feel unwell:

  • I reassess gut health: dysbiosis, SIBO, post-viral inflammation, food sensitivities. The gut-liver axis modulates thyroid hormone metabolism and immune cross-talk, particularly in Hashimoto’s.
  • I commonly see symptom breakthroughs after:
    • Eliminating trigger foods (gluten in celiac spectrum; individualized otherwise),
    • Repleting selenium, zinc, iron, vitamin D, B12, and magnesium, and
    • Restoring sleep and movement rhythm.

Integrative chiropractic fit:

  • Vagal stimulation through breathing and thoracic mobilization, coupled with graded walking and core stability, improves motility and lowers systemic inflammatory tone.

Clinical Vignettes And Observations From Practice

  • Ferritin plateaus despite oral iron: With alternating-day dosing with vitamin C, stopping concurrent calcium, checking for H. pylori and celiac markers, and adding diaphragmatic breathing drills for reflux, patients often see ferritin rise to 60–100 ng/mL within 12–16 weeks. Combining manual therapy to reduce costal margin restriction improved tolerance of iron and reduced GERD complaints in my clinic.
  • Progesterone intolerance in perimenopause: Switching from 200 mg oral nightly to 50–100 mg sublingual in divided evening doses, plus cervical release and sleep hygiene, stabilized mood and sleep within two cycles for most sensitive patients.
  • Young male with low T and fatigue: A 9-month plan emphasizing whole-food nutrition, vitamin D repletion to 40–60 ng/mL, magnesium glycinate at night, and progressive resistance training raised total testosterone from 320 ng/dL to 760 ng/dL without medications. Thoracic mobility and hip hinge training improved recovery and adherence.
  • Post-DCIS symptom burden: In a patient more than a decade post-bilateral mastectomy with severe vasomotor symptoms, a carefully titrated transdermal estradiol patch with nightly progesterone, plus scapular mobility and postural rehabilitation, improved sleep and cognition. Shared decision-making and documented informed consent were essential.

Why Integrative Chiropractic Care Amplifies Endocrine Therapies

  • Autonomic regulation: Pain and joint dysfunction heighten sympathetic tone, disrupting sleep, glucose metabolism, and thyroid hormone conversion. Manual therapy, spinal mobilization, and breathing retraining shift HRV toward parasympathetic balance, creating a biological environment in which hormones function as intended.
  • Movement economy: Efficient biomechanics reduce inflammatory signaling from microtrauma and improve insulin sensitivity, crucial for PCOS, TRT safety, and thyroid action.
  • Adherence and feedback loops: Rapid musculoskeletal relief builds trust and momentum, making it easier to sustain nutrition, sleep, and medication regimens. Clinically, I consistently see greater lab improvements when patients are engaged in both structured movement and manual care.

Practical Protocol Checklists

Iron and ferritin

  • Assess ferritin, iron, TIBC, transferrin saturation, CRP, ESR, CBC, retic Hb.
  • Identify cause: menses, GI loss, malabsorption, diet, PPI use.
  • Replace with alternate-day dosing; recheck at 8–12 weeks.
  • Add diaphragmatic breathing and gentle conditioning.

Progesterone strategies

  • Start 100–200 mg oral micronized qHS; if intolerant, consider 50–100 mg sublingual divided.
  • For estrogen users, ensure endometrial protection.
  • In the history of endometriosis, there is a continued use of estrogen and progesterone even post-hysterectomy.

Cortisol evaluation

  • Use 4–5-point salivary cortisol to assess diurnal rhythm; AM serum for insufficiency screening.
  • Implement light therapy, sleep hygiene, and autonomic-balancing manual care.

Male fertility/TRT

  • For fertility: short-course clomiphene 3–6 months with lifestyle-based.
  • On TRT: monitor hematocrit, estradiol, SHBG, PSA, BP; address sleep apnea.
  • Optimize resistance training and recovery.

Thyroid optimization

  • If reverse T3 is high and symptoms persist, investigate inflammation and gut.
  • Consider T3 add-on or desiccated thyroid with careful monitoring.
  • Support with selenium, zinc, iron, and vitamin D; improve sleep and stress load.

Estriol/estradiol

  • Use local estradiol or estriol for urogenital symptoms; monitor if combining with estradiol systemically.
  • Expect estriol alone to be too weak for hot flashes.

Closing Perspective

Modern endocrine care thrives at the intersection of precise physiology and whole-person mechanics. When we calibrate hormones thoughtfully, correct nutrient deficits, and restore movement and autonomic balance, patients experience durable improvements in energy, cognition, metabolism, and quality of life. Integrative chiropractic care is not an add-on; it is a force multiplier—aligning the nervous system and musculoskeletal frame to receive and respond to biochemical therapies. My day-to-day observations mirror the literature: when we treat the individual and the system, outcomes follow.

References

A Modern, Integrative Approach to Thyroid Optimization

A Modern, Integrative Approach to Thyroid Optimization

A Modern, Integrative Approach to Thyroid Optimization

Abstract

For decades, the standard approach to treating hypothyroidism has centered on a single lab value—Thyroid-Stimulating Hormone (TSH)—and a single medication, synthetic T4 (levothyroxine). However, an increasing body of evidence and extensive clinical observations indicate that this approach is fundamentally flawed for a significant proportion of patients. Many individuals on T4-only therapy continue to suffer from debilitating hypothyroid symptoms like fatigue, weight gain, hair loss, and depression, despite their TSH levels appearing “normal.” This educational post will explore the intricate physiology of thyroid hormone, explaining why T4 is a prohormone and why active T3 is the key to metabolic health. We will deconstruct the limitations of TSH testing, explore the critical process of T4-to-T3 conversion, and introduce the problematic role of Reverse T3. Drawing from the latest evidence-based research and my own clinical experience, I will outline a more comprehensive, patient-centered approach to diagnosing and managing thyroid dysfunction. We will discuss the vital importance of Free T3 (FT3), the shortcomings of standard lab ranges, and the clinical benefits of combination therapy, including Natural Desiccated Thyroid (NDT). Furthermore, I will explain the critical, yet often overlooked, role of iodine and how integrative chiropractic care forms a foundational part of treatment by optimizing nervous system function and supporting the body’s innate ability to heal.

Rethinking Thyroid Care: Moving Beyond Outdated Protocols

As a practitioner with credentials spanning chiropractic, advanced practice nursing, and functional medicine (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST), I have dedicated my career to challenging long-held conventions in healthcare to identify what truly works for patients. Today, I want to guide you on a journey into the world of the thyroid, and in doing so, I may need to unravel some of what you’ve come to understand from conventional medical training. My goal is not to create a new, complicated system but to return to a more fundamental, physiological truth. My goal is to assist individuals in returning to a lifestyle that aligns with the natural and optimal design of our bodies.

For over a decade, I’ve focused on this physiological approach, and the feedback from patients at my clinic has been overwhelmingly positive. They feel better, their symptoms resolve, and their lives are transformed. This isn’t based on a fad; it’s grounded in pure physiology. When we appreciate and work with the body’s intricate systems instead of against them, we see profound clinical success. This is particularly true when it comes to the thyroid.

Thyroid Hormone: Your Body’s Metabolic Engine

The thyroid hormone is the master regulator of your metabolism. It dictates the speed of nearly every cellular process in your body. Think of it as the engine’s pace car. It controls:

  • Energy Production: Your overall rate of energy expenditure.
  • Temperature Regulation: Why you might feel cold when others are comfortable.
  • Growth Rates: How fast your hair and nails grow.
  • Gastrointestinal Motility: The speed of your digestive system influences constipation or diarrhea.
  • Cellular Health: Research has even linked low levels of the active thyroid hormone T3 to an increased risk of certain cancers.

The Synthroid Paradox: Normal Labs, Persistent Symptoms

The most widely prescribed thyroid medication in history is levothyroxine, with Synthroid being the most recognizable brand name. Yet, in my clinical practice, I see a daily parade of patients who are taking it and are still miserable. I recently saw a patient who had been on a stable dose of Synthroid for years. Her endocrinologist told her that her labs were perfect, with a TSH of 1.5. Yet, her chart told a different story.

  • Chief Complaint: Fatigue. She was exhausted.
  • Clinical Signs: She was wearing a thick jacket in my office… in the middle of a Texas July.
  • Other Symptoms: She was constipated, and her hair was falling out in clumps.

Her labs may have looked “normal,” but she was a walking textbook of hypothyroid symptoms. If her thyroid replacement were truly working, she would not have these symptoms. Clearly, something was not right.

This scenario is the direct result of a historical confluence of events. Synthroid was approved around 1960 based on two simple criteria: it normalized the TSH, and it didn’t cause immediate harm. It was never studied for its ability to resolve the clinical symptoms of hypothyroidism. Around the same time, the ultra-sensitive TSH assay was developed and quickly became the “gold standard” lab test.

Medical schools and residency programs immediately adopted this new paradigm: Diagnose with TSH, treat with Synthroid, and monitor with TSH. This simplistic loop became dogma. The patient’s well-being became secondary to achieving a “normal” lab number. This is a fundamental flaw in modern endocrinology, and it’s leaving millions of patients to suffer unnecessarily.

Redefining Hypothyroidism: A Deeper Look at T3 and T4

To fix this problem, we must first redefine it. The conventional definition of hypothyroidism is based on a lab test. A functional and more accurate definition focuses on the body’s physiological state.

  • Type 1 Hypothyroidism: This is a production problem. The thyroid gland itself is not producing enough hormone. This can be due to surgical removal, radioactive iodine ablation, autoimmune destruction (Hashimoto’s disease), or glandular burnout from chronic stress.
  • Type 2 Hypothyroidism: This is a conversion problem. The body is unable to effectively convert the inactive storage hormone (T4) into the active, usable hormone (T3). This is where the standard T4-only treatment model fails.
  • Type 3 Hypothyroidism: This is a receptor issue in which cellular receptors become resistant to thyroid hormone, often due to inflammation or illness.

The thyroid gland produces a hormone called thyroxine (T4), which contains four iodine atoms. To become metabolically active, it must lose one iodine atom to become triiodothyronine (T3). T3 has five times the affinity for the thyroid receptor as T4. This means T3 is the hormone that does the heavy lifting. T4 is simply the raw material we store to make T3 whenever we need it. You live off your T3.

The Critical Flaw of TSH Testing and Deiodinase Dysfunction

The TSH test was designed as a screening test for an asymptomatic population to see if they are at risk for a thyroid condition. The inventor of the assay himself stated it was never intended to be used to monitor or guide therapy for a treated patient. So why is it the cornerstone of modern treatment? Because it makes the lab reports look good, providing a false sense of security for practitioners while patients remain unwell.

A pivotal study published by Escobar-Morreale et al. (1997) shed light on this discrepancy. Researchers discovered that the concentration of T3 varied significantly in different tissues throughout the body—the liver, kidneys, and muscles. But there was one place where T3 levels remained stable, even when they were low everywhere else: the brain.

This is because the brain and pituitary gland exhibit a unique, highly concentrated expression of the enzyme deiodinase type 2 (D2). This enzyme is responsible for converting T4 into the active T3. The rest of your body—the periphery—also uses D2, but a host of common stressors can downregulate its activity there while leaving it untouched in the pituitary.

What does this mean? It means your pituitary gland—the very organ that produces TSH—lives in a “T3 bubble,” isolated from the reality of what’s happening in the rest of your body. Your muscles, liver, and fat cells can be starving for T3, but your brain’s T3 level can remain perfectly normal. Consequently, your pituitary sees no problem and keeps the TSH level low and “normal.” Your pituitary gland has no idea what the T3 level is in your big toe, and TSH cannot tell us. This is why a patient can have a “perfect” TSH and still feel terrible.

The Roadblock: Reverse T3 and Poor Conversion

The body has a protective buffer system. Under conditions of stress, inflammation, illness, or nutrient deficiency, the body can divert T4 down a different path. Instead of converting to active T3, it uses a different enzyme, deiodinase type 3 (D3), to convert T4 into an inactive form called Reverse T3 (rT3).

Reverse T3 has the same shape as active T3, allowing it to fit into the thyroid receptor. However, it is a dud. It doesn’t turn the engine on. Instead, it sits there, blocking active T3 from getting to the receptor.

When you give a patient a large dose of T4, especially if they have underlying inflammation or stress, their body often perceives it as a threat. To protect itself from becoming overstimulated, it down-regulates D2 (making less active T3) and up-regulates D3 (making more inactive Reverse T3). The result? The patient’s TSH goes down, their labs look “good,” but their symptoms get worse because their cells are being flooded with an inactive blocker hormone.

A landmark study from Israel beautifully outlines the myriad factors that impair the conversion of T4 to T3:

  • Psychological and Physical Stress: High cortisol is a potent inhibitor.
  • Insulin Resistance and Diabetes: Poor blood sugar control disrupts thyroid function.
  • Inflammation: Cytokines from injury, infection, or chronic disease impair deiodinase enzymes.
  • Autoimmune Disease: Conditions such as Hashimoto’s cause chronic inflammation.
  • Nutrient Deficiencies: Deficiencies in key minerals like iron (ferritin) and selenium are critical cofactors for deiodinase enzymes.
  • Aging: The natural process of aging reduces conversion efficiency, as noted by Duntas & Biondi (2011).

Considering this list, it’s clear that the vast majority of people are not converting T4 to T3 optimally, creating an epidemic of subclinical, functional hypothyroidism.

The Heart of the Matter: Low T3 Syndrome and Cardiovascular Risk

The medical field that has most urgently recognized the danger of this condition is cardiology. An overwhelming body of research now links Low T3 Syndrome directly to poor outcomes in cardiovascular disease. A landmark study by Iervasi et al. (2003) found that in patients with heart disease, a low T3 level was a strong prognostic predictor of death, whereas TSH had no predictive value.

Why is this the case? The myocardium, or heart muscle, is exquisitely sensitive to T3. It relies on adequate T3 for proper contractility, rhythm, and overall function. When serum T3 is low, the heart is essentially starved of its primary metabolic fuel. Historically, how did patients with profound, untreated hypothyroidism die? Almost universally from cardiovascular events. A healthy Free T3 level is a critical component of cardiovascular protection. Patients in the lower part of the lab reference range can have a 33% to 66% higher risk of all-cause and cardiovascular mortality compared to those in the upper range (Pingitore, Iervasi, & Chopra, 2008).

The Problem with “Normal”: Redefining Lab Reference Ranges

This brings me to a fundamental problem in conventional medicine: our reliance on statistically “normal” reference ranges. Let’s say the lab reference range for Free T3 is 2.2 to 4.2 pg/mL. A patient comes to me with a level of 2.3 pg/mL. They have been told their thyroid is “normal.” Yet, they are exhausted, their hair is falling out, and they can’t lose weight.

What does being in the 10th percentile of the reference range truly mean? It means 90% of the population has more of this vital, energy-giving hormone than you do. Does that sound optimal? Of course not. My approach is to move patients from the bottom of the range to a more optimal position, typically aiming for the top quartile (75th percentile and above). I am not treating a lab number; I am treating a patient.

A Modern, Evidence-Based Treatment Protocol

So, how do we put all this knowledge into practice? Here is the approach I use, which is grounded in the latest research and my clinical experience.

1. Comprehensive Lab Testing

A TSH-only screen is inadequate. I order a full panel that includes TSH, Free T4, Free T3, and Thyroid Antibodies (TPO and TgAb). If a patient is on T4-only medication and still has symptoms, I always order a Reverse T3 (RT3) test. This panel gives us the complete picture.

2. Choosing the Right Medication

The evidence and patient satisfaction surveys point to a clear conclusion: T4-only therapy is not effective for a significant portion of the population. A 2018 online survey of over 12,000 thyroid patients found that those taking Natural Desiccated Thyroid (NDT), which contains both T4 and T3 (such as NP Thyroid or Armor Thyroid), reported significantly higher satisfaction with their treatment (Peterson et al., 2018).

NDT is derived from porcine thyroid glands and contains T4 and T3 in a ratio very similar to the human thyroid. It provides the body with the active hormone it needs directly, bypassing potential conversion issues. When transitioning a patient from a synthetic T4 medication, I use a careful overlap protocol to allow the body to acclimate smoothly.

3. Standardizing Lab Draws and Dosing

T3 has a very short half-life of about 18-24 hours. To obtain meaningful and consistent data, testing must be standardized. I instruct all my patients to have their blood drawn five to six hours after taking their morning dose. This provides us with a consistent point on the absorption curve.

For my patients with Type 1 hypothyroidism—those without a functioning thyroid—a significant breakthrough has been the introduction of a second, afternoon dose of NDT. Because of T3’s short half-life, a single morning dose often leads to a “crash” by 3 or 4 p.m. By splitting their total daily dose, we maintain a more stable level of active T3, transforming their energy and quality of life.

The Critical, Overlooked Role of Iodine

I cannot overstate the importance of iodine for thyroid health and overall well-being. The Recommended Dietary Allowance (RDA) in the U.S. is a mere 150 micrograms, an amount established simply to prevent goiter, not to promote optimal health. In stark contrast, the average daily intake of iodine in Japan is over 13 milligrams (13,000 micrograms), primarily from seaweed. The correlation with cancer rates is alarming; Japan has significantly lower rates of breast and prostate cancer. As Dr. David Brownstein explains in his book, Iodine: Why You Need It, Why You Can’t Live Without It, this is likely not a coincidence.

Iodine is essential not just for the thyroid but for breast tissue, the prostate, ovaries, and every cell in the body. When you begin supplementing an iodine-deficient person, TSH will temporarily rise. This is the body’s intelligent response to produce more sodium-iodide symporters (NIS)—the gateways that pull iodine into the cells. An uninformed practitioner might see this TSH spike and wrongly conclude that the iodine is harmful. This is why I tell my patients we will not check a TSH level for at least nine months after starting iodine therapy. Free T3 and the patient’s symptoms are our true guides.

Integrative Chiropractic Care: The Neurological Connection

As a Doctor of Chiropractic (DC), I view the body through the lens of the nervous system as the master controller of all other systems, including the endocrine system. The connection among the spine, the nervous system, and thyroid function is a critical yet often-overlooked piece of the puzzle.

The thyroid gland receives its nerve supply from the cervical spine. Misalignments, or vertebral subluxations, in this area can interfere with the nerve signals traveling between the brain and the thyroid. This can disrupt the delicate feedback loop of the hypothalamic-pituitary-thyroid (HPT) axis.

How Chiropractic Fits In:

  • Restoring Nerve Function: Through specific, gentle chiropractic adjustments, we can correct subluxations in the cervical spine. This restores proper nerve flow, ensuring the brain and thyroid can communicate effectively. In my clinic, I have observed that patients receiving regular chiropractic care often see improvements in their thyroid function.
  • Reducing Systemic Stress: The chiropractic adjustment has a powerful effect on the autonomic nervous system, helping to shift the body from a “fight-or-flight” (sympathetic) state to a “rest-and-digest” (parasympathetic) state. Chronic stress elevates cortisol levels, which inhibit the conversion of T4 to T3. By modulating the stress response through chiropractic care, we create a more favorable hormonal environment for optimal thyroid function.
  • Holistic Support: Integrative chiropractic care encompasses nutritional counseling, lifestyle recommendations, and stress management techniques, all of which are foundational to supporting endocrine health.

By integrating chiropractic adjustments with functional medicine protocols, we address both the biochemical and neurological aspects of thyroid dysfunction, providing a truly comprehensive and powerful path to healing. Ultimately, our goal is not just to fix a lab value. It is to listen to our patients, to understand the deep physiological imbalances at play, and to use every evidence-based tool at our disposal to restore health and change lives.

References

Brownstein, D. (2014). Iodine: Why you need it, why you can’t live without it (5th ed.). Medical Alternatives Press.

Duntas, L. H., & Biondi, B. (2011). The aging thyroid: a challenge for the clinician. Nature Reviews Endocrinology, 7(9), 558–560. https://www.nature.com/articles/nrendo.2011.83

Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1997). Tissue-specific patterns of changes in 3,5,3′-triiodothyronine concentrations in hypothyroid rats. Endocrinology, 138(6), 2494-2503. https://doi.org/10.1210/endo.138.6.5186

Guo, T., Wang, Y., Zhang, Y., Ma, J., & Wang, F. (2022). Lower free triiodothyronine levels are associated with major depressive disorder and its symptom severity. Psychoneuroendocrinology, 146, 105952. https://doi.org/10.1016/j.psyneuen.2022.105952

Iervasi, G., Pingitore, A., Landi, P., Raciti, M., Ripoli, A., Scarlattini, M., L’Abbate, A., & Donato, L. (2003). Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation, 107(5), 708–713. https://www.ahajournals.org/doi/10.1161/01.cir.0000048039.63811.23

Peeters, R. P., Wouters, P. J., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2003). Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. The Journal of Clinical Endocrinology & Metabolism, 88(10), 4559–4565. https://academic.oup.com/jcem/article/88/10/4559/2845213

Peterson, S. J., Cappola, A. R., Castro, M. R., Dayan, C. M., Farwell, A. P., Hescox, M., & … Bianco, A. C. (2018). An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid, 28(6), 707–721. https://doi.org/10.1089/thy.2017.0681

Pingitore, A., Iervasi, G., & Chopra, I. J. (2008). The role of thyroid hormone in the heart. Journal of Clinical Endocrinology & Metabolism, 93(6), 1957–1964.

Shakir, M. K., Brooks, B. A., & Crooks, L. A. (2007). The significance of a suppressed TSH in hypothyroid patients on levothyroxine. Endocrine Practice, 13(1), 16-20. https://doi.org/10.4158/EP.13.1.16

Starr, M. (2005). Hypothyroidism Type 2: The epidemic. Mark Starr Trust.

Woeber, K. A. (2002). Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. Journal of Endocrinology and Metabolism, 87(9), 3986-3990. https://doi.org/10.1210/jc.2002-020580